10-Q: Bellevue Life Sciences Acquisition Corp. Reports Q2 2024 Results, Faces Liquidity Concerns
Sentiment:
Quarterly Report
Bellevue Life Sciences Acquisition Corp. reported a net loss for the second quarter of 2024 and is facing substantial doubt about its ability to continue as a going concern due to liquidity issues.
Delay expectedThe company has extended its deadline to complete a business combination multiple times, with the current deadline being November 14, 2024.
Capital raiseThe company has issued multiple promissory notes to its sponsor, totaling $1,690,000, which are due on the earlier of December 31, 2024, or the consummation of a business combination.The company may need to raise additional capital to meet the minimum cash condition for the proposed business combination with OSR Holdings.
Worse than expectedThe company reported a net loss and has a significant working capital deficit.The company is facing substantial doubt about its ability to continue as a going concern.The company is not in compliance with Nasdaq's minimum public holders requirement.
Summary
- Bellevue Life Sciences Acquisition Corp. (BLAC) reported a net loss of $97,295 for the three months ended June 30, 2024, and a net loss of $157,725 for the six months ended June 30, 2024.
- The company's cash balance stood at $119,116 as of June 30, 2024, with a working capital deficit of $3,251,300.
- BLAC has extended its deadline to complete a business combination to November 14, 2024, after multiple extensions and redemptions of shares.
- The company has a proposed business combination with OSR Holdings Co. Ltd., but it is subject to various closing conditions, including a minimum cash requirement of $5,000,001.
- The company has received a notice from Nasdaq regarding non-compliance with the minimum public holders requirement and has until August 13, 2024, to regain compliance.
- Management has expressed substantial doubt about the company's ability to continue as a going concern due to insufficient working capital and the approaching deadline for completing a business combination.
Sentiment
Score: 2
Explanation: The document indicates significant financial challenges, including net losses, a substantial working capital deficit, and a going concern warning. The company is also facing Nasdaq delisting risk and has had to extend its business combination deadline multiple times. The sentiment is very negative due to the high level of uncertainty and risk.
Positives
- The company has secured a proposed business combination with OSR Holdings Co. Ltd.
- The company has extended its deadline to complete a business combination to November 14, 2024, providing more time to finalize a deal.
- The company has received an extension from Nasdaq to regain compliance with the minimum public holders requirement.
Negatives
- The company reported a net loss for both the three and six months ended June 30, 2024.
- The company has a significant working capital deficit of $3,251,300.
- The company is facing substantial doubt about its ability to continue as a going concern.
- The company is not in compliance with Nasdaq's minimum public holders requirement.
- The company has incurred significant redemptions from its trust account, reducing available funds.
- The proposed business combination is subject to a minimum cash condition of $5,000,001, which may be difficult to achieve.
Risks
- The company may not be able to complete a business combination by the November 14, 2024 deadline, leading to liquidation.
- The company may not be able to raise sufficient capital to meet the minimum cash condition for the proposed business combination.
- The company may be delisted from Nasdaq if it fails to regain compliance with the minimum public holders requirement by August 13, 2024.
- The company's financial condition raises substantial doubt about its ability to continue as a going concern.
- The company's reliance on loans from its sponsor and affiliates may not be sustainable.
- The company's proposed business combination is subject to various closing conditions, which may not be met.
Future Outlook
The company's future is highly dependent on its ability to complete a business combination by November 14, 2024, and to raise sufficient capital to meet the minimum cash condition for the proposed business combination with OSR Holdings. The company's management has expressed substantial doubt about its ability to continue as a going concern.
Management Comments
- Management believes that the Company will not have sufficient working capital to meet its working capital needs through the earlier of the consummation of an Initial Business Combination or 21 months from the Initial Public Offering.
- Management intends to complete a business combination.
Industry Context
This announcement is typical for a SPAC that is nearing its deadline to complete a business combination. The company's struggles with liquidity and Nasdaq compliance are not uncommon in the SPAC market, which has seen increased scrutiny and redemptions in recent times.
Comparison to Industry Standards
- The high redemption rates experienced by BLAC are consistent with trends in the SPAC market, where investors have become more cautious and are increasingly opting to redeem their shares rather than participate in business combinations.
- The company's working capital deficit and going concern issues are more severe than many other SPACs, indicating a higher level of risk.
- The company's reliance on sponsor loans is a common practice in the SPAC industry, but the amount of debt and the uncertainty of repayment raise concerns.
- The company's struggle to maintain Nasdaq listing compliance is a common issue for SPACs with low public float and high redemption rates.
Related Party Transactions
- The company has entered into multiple promissory note agreements with its sponsor.
- The company pays a monthly fee of $7,500 to an affiliate of its sponsor for administrative support.
- The company has a due to affiliate balance of $57,000 as of June 30, 2024.
Stakeholder Impact
- Shareholders face the risk of losing their investment if the company fails to complete a business combination and is liquidated.
- Employees may face job uncertainty if the company is unable to continue as a going concern.
- Creditors face the risk of not being repaid if the company is liquidated.
- The company's proposed business combination with OSR Holdings is subject to various closing conditions, which may impact the target company's stakeholders.
Next Steps
- The company must complete a business combination by November 14, 2024.
- The company must regain compliance with Nasdaq's minimum public holders requirement by August 13, 2024.
- The company must secure sufficient funding to meet the minimum cash condition for the proposed business combination with OSR Holdings.
- The company must obtain stockholder approval for the proposed business combination.
Key Dates
| Date | Description |
|---|---|
| 2020-02-25 | Bellevue Life Sciences Acquisition Corp. was incorporated in Delaware. |
| 2020-07-30 | Sponsor purchased 1,437,500 founder shares. |
| 2022-02-17 | Company repaid $10,000 to the Sponsor. |
| 2022-04-25 | Company executed a 1.2-for-one stock split, resulting in 1,725,000 Founder Shares. |
| 2022-04-28 | Sponsor agreed to advance the Company up to an additional $10,000. |
| 2022-04-29 | Sponsor agreed to advance an additional $7,000. |
| 2023-02-09 | Registration statement for the company's Initial Public Offering was declared effective. |
| 2023-02-14 | Company consummated the Initial Public Offering. |
| 2023-02-17 | Underwriters exercised their over-allotment option in full. |
| 2023-02-21 | Closing of the issuance and sale of the Over-Allotment Option Units. |
| 2023-03-01 | Company agreed to pay BCM $7,500 per month for administrative support. |
| 2023-06-23 | Sponsor loaned the company $200,000. |
| 2023-06-28 | Company notified Nasdaq of non-compliance with listing rule 5605(c)(2)(A). |
| 2023-11-09 | Company held a special meeting of its stockholders and approved an extension of the business combination deadline. |
| 2023-11-13 | Company deposited $180,000 into the Trust Account and BCM loaned the company $180,000. |
| 2023-11-14 | Previous deadline for business combination. |
| 2023-11-16 | Company entered into a Business Combination Agreement with OSR Holdings Co. Ltd. |
| 2024-02-09 | Second Certificate of Amendment to the Charter was filed, extending the business combination deadline to May 14, 2024 and Company issued an unsecured promissory note to Jun Chul Whang for $75,000. |
| 2024-02-14 | First extended deadline for business combination. |
| 2024-02-15 | Company received a notification from Nasdaq regarding non-compliance with the minimum public holders requirement. |
| 2024-03-08 | Company issued an unsecured promissory note to Josh Pan for $60,000. |
| 2024-03-12 | Company deposited $60,000 into the Trust Account. |
| 2024-04-01 | Company submitted a plan to regain compliance with the Minimum Public Holders Rule to Nasdaq. |
| 2024-04-08 | Company issued an unsecured promissory note to the Sponsor for $1,200,000. |
| 2024-04-09 | Company deposited $60,000 into the Trust Account. |
| 2024-04-17 | Company received written notice from Nasdaq granting an extension to regain compliance with the Minimum Public Holders Requirement and Company issued an unsecured promissory note to the Sponsor for $50,000 and Company withdrew $100,000 of interest income from the Trust Account. |
| 2024-05-10 | Company convened a special meeting of its stockholders and adjourned without any business being conducted. |
| 2024-05-14 | Company reconvened the special meeting and approved an extension of the business combination deadline to November 14, 2024, Company deposited $50,000 into the Trust Account and Company issued an unsecured promissory note to the Sponsor for $140,000. |
| 2024-05-23 | Company and OSR Holdings entered into an Amended and Restated Business Combination Agreement. |
| 2024-06-07 | Resignation of directors, leading to non-compliance with Nasdaq rules. |
| 2024-06-13 | Company notified Nasdaq of non-compliance with additional listing rules and Company deposited $50,000 into the Trust Account. |
| 2024-06-21 | Resignation of a director, leading to non-compliance with Nasdaq rules. |
| 2024-06-23 | Company regained compliance with Nasdaq listing rules. |
| 2024-06-30 | End of the reporting period for the quarterly report. |
| 2024-07-11 | Company issued an unsecured promissory note to the Sponsor for $300,000. |
| 2024-07-12 | Company deposited $50,000 into the Trust Account. |
| 2024-08-13 | Company must file documentation with Nasdaq to demonstrate compliance with the minimum public holders requirement and Company deposited $50,000 into the Trust Account. |
| 2024-08-15 | Date of share count for the report. |
| 2024-08-19 | Date of the report. |
| 2024-11-14 | Current deadline for business combination. |
| 2024-12-31 | Maturity date for several promissory notes. |
Keywords
SPAC, Business Combination, Liquidity, Redemption, Nasdaq, Going Concern, OSR Holdings, Promissory Notes, Working Capital, Financial Results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.